好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Bilateral facial paralysis as first clinical manifestation in HIV positive patient
General Neurology
P1 - Poster Session 1 (9:00 AM-5:00 PM)
171

To report an atypical case of bilateral facial paralysis in HIV positive hispanic patient and evaluate possible pathological mechanism.

Although idiopathic Bell’s palsy is commonly reported, bilateral facial paralysis (BFP) manifestation is very rare, mostly presenting secondary to underlying medical conditions. The exact mechanism of BFP in HIV infection is poorly understood, however, a correlation between direct HIV infection of the geniculate ganglion and/or direct immune response to acute viremia is proposed.

A 52 year old Hispanic female with history of bipolar and generalized anxiety disorders presents to the emergency room after experiencing facial paralysis on the left side for four days. Patient with history of right facial paralysis one month ago that improved with methylprednisolone for 7 days. The patient has a pertinent history of non-intentional weight loss of 20 pounds in the last year and former smoker 1 pack per day for the last 35 years. The physical findings are remarkable for left hyperacusis and left facial paralysis with incomplete left eye closure (House-Brackmann Scale of IV). Laboratories pertinent for elevated ESR of 54, HIV positive for antibodies and CD4 count of 724 cells/uL, (23.3% lymphocytes). CSF microbiology with evidence of atypical cells showing hyperchromatic irregular nuclei and scant cytoplasm. The brain MRI with contrast revealed abnormal contrast enhancement spanning the labyrinthine, tympanic, mastoid and extratemporal parotid segments of both facial nerves. Cervical lymph node biopsy with evidence of polyclonal plasmacytosis. She was treated with HAART therapy upon discharge, with marked clinical improvement.

NA

Here we present an uncommon case of an HIV-positive patient with the first clinical manifestation of BFP, which can occur in both early, as in this case, (without any other symptoms) and advances stages of HIV. Therefore, it is crucial to associate BFP with HIV for early management and prevention of HIV transmission.

Authors/Disclosures
Melissa A. Morales Garcia, MD
PRESENTER
Dr. Morales Garcia has nothing to disclose.
Jessica Abreu Garcia, MD Dr. Abreu Garcia has nothing to disclose.
Raymond M. Rivera Vergara, MD Dr. Rivera Vergara has nothing to disclose.
Cristina A. Cruz, MD (Urb. Mansiones Reales) Dr. Cruz has nothing to disclose.
Marelisa Albelo Martinez, MD (Neurology Program, University of Puerto Rico) Dr. Albelo Martinez has nothing to disclose.
No disclosure on file
Gishlaine Alfonso, MD, FAAN Dr. Alfonso has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion .
Valerie E. Wojna, MD, FAAN (Nuerology Division, UPR MSC SoM) Dr. Wojna has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Puerto Rico Health Sciences Journal, University of Puerto Rico Medical Sciences Campus. The institution of Dr. Wojna has received research support from NIH.